All notes
144 entries across chemistry, analytical methods, storage, and regulatory topics.
-
Thioflavin T fluorescence and peptide fibrillation kinetics: lag phase, elongation, and what the plateau does not report
Thioflavin T is the standard kinetic readout for peptide fibril formation. This post covers what the dye binds, how the sigmoidal curve is read, and its limits.
-
Size-exclusion chromatography for peptides: secondary interactions, mobile phase design, and calibration limits
Size-exclusion chromatography is used to resolve peptide oligomers from monomer, but small peptides sit at the edge of its range. This post covers column selection, mobile phase, and calibration.
-
Carryover and ghost peaks in peptide HPLC: what blank injections reveal about adsorption, memory effects, and purity figures
Peptides adsorb to surfaces and re-emerge in later runs. This post reviews carryover mechanisms, blank-injection design, and how artifacts distort reported purity values.
-
FTIR amide I analysis of lyophilized peptide solids: what the band shape reports and where interpretation breaks down
Infrared spectroscopy can probe peptide conformation directly in the freeze-dried state. This post reviews amide I band assignment, second-derivative methods, and interpretive limits.
-
Lyophilized cake appearance: what shrinkage, cracking, and meltback do and do not tell you about a peptide vial
The appearance of a freeze-dried cake reflects process history more than chemistry. This post reviews cake attributes, their physical origins, and interpretive limits.
-
Dynamic light scattering and sub-micron peptide assemblies: what the autocorrelation function can and cannot report
Dynamic light scattering detects peptide assemblies that HPLC and visual inspection miss. This post reviews intensity weighting, polydispersity, and interpretive limits.
-
Sterility Testing Under USP <71>: Membrane Filtration, Direct Inoculation, and Method Suitability for Peptide Solutions
A sterility test result is only as meaningful as its method suitability. How USP <71> compendial sterility testing is structured, and why peptide matrices complicate it.
-
Nonionic surfactants in peptide formulations: interfacial protection and the polysorbate degradation problem
Polysorbates are added to peptide solutions to limit interfacial adsorption and aggregation, yet they carry their own peroxide and hydrolysis liabilities. A chemical overview.
-
Buffer species and general acid-base catalysis: why the same pH in two buffers is not the same condition for a peptide
Phosphate, acetate, and citrate can hold a peptide solution at the same pH yet change degradation rates differently. This post reviews buffer catalysis and its limits.
-
Headspace oxygen and nitrogen backfill: what the gas above a lyophilized peptide can and cannot control
Lyophilized peptide vials are often backfilled with nitrogen. This post reviews how headspace oxygen is measured, what it limits, and where its influence ends.
-
What ISO/IEC 17025 accreditation does and does not establish about a peptide testing laboratory
A laboratory logo on a certificate of analysis says little without its scope. This post reviews what ISO/IEC 17025 accreditation covers and where its limits lie.
-
Column selection for peptide RP-HPLC: pore size, particle architecture, and stationary phase chemistry
Peptide purity values depend on the column as much as the gradient. How pore size, superficially porous particles, and bonded phase chemistry shape peptide separations.
-
MALDI-TOF mass spectrometry for synthetic peptides: matrix selection, ionization behavior and limits
MALDI-TOF offers rapid intact-mass confirmation of synthetic peptides. This post reviews matrix choice, ion suppression, calibration and what a spectrum can and cannot establish.
-
Trace metals and peptide oxidation: how copper and iron drive metal-catalyzed degradation
Trace copper and iron can accelerate oxidation of histidine, methionine and cysteine residues. This post reviews the chemistry, analytical signatures and handling variables.
-
Two-dimensional NMR of synthetic peptides: TOCSY, NOESY, and HSQC for identity and conformation
How TOCSY, NOESY/ROESY, and HSQC experiments assign spin systems and probe conformation in synthetic peptides, and what each can and cannot establish on a certificate.
-
Counting the counterions: ion chromatography and 19F NMR for the salt fraction of a synthetic peptide
Counterion content can account for a large share of a lyophilized peptide's mass. This post reviews ion chromatography and 19F NMR methods and their interpretive limits.
-
Reading backbone dynamics by exchange: hydrogen-deuterium exchange mass spectrometry for peptide characterization
Hydrogen-deuterium exchange mass spectrometry tracks amide protection to probe peptide structure. This post reviews the kinetics, workflow, and interpretive limits.
-
Heat as a stability signal: isothermal microcalorimetry and the degradation kinetics of peptide solids
Isothermal microcalorimetry detects the heat released by slow degradation in an intact vial. This post reviews what heat flow shows about peptide stability.
-
Amorphous or crystalline? X-ray powder diffraction and the solid-state character of lyophilized peptides
Lyophilized peptides are usually amorphous solids. This post reviews what X-ray powder diffraction can and cannot show about solid-state form and stability.
-
Bacterial endotoxin testing of peptide preparations: LAL interference, recovery, and what a pass result establishes
Endotoxin assays based on Limulus lysate are sensitive to peptide chemistry. This post reviews interference mechanisms, spike recovery, and the scope of a reported result.
-
Stable isotope-labeled internal standards in peptide LC-MS quantitation: what isotopic purity and label choice determine
Stable isotope-labeled peptides serve as internal standards in LC-MS quantitation. This post covers label selection, isotopic purity, and cross-signal contributions.
-
Ion mobility spectrometry and peptide isomers: collision cross section as an orthogonal identity dimension
Ion mobility separates gas-phase peptide ions by size and shape, resolving isomers that share a mass. This post covers drift time, collision cross section, and what the added dimension can show.
-
Retro-inverso peptides: reversed sequences, D-amino acids, and the characterization problem
Retro-inverso design reverses a sequence and inverts chirality to preserve side-chain topology. What the concept implies for synthesis, identity testing, and chiral purity.
-
Glycation in lyophilized peptides: Maillard chemistry, reducing sugars, and the +162 Da peak
Reducing sugars in a lyophilized cake can modify primary amines over time. How Maillard chemistry works in the solid state and how it appears in LC-MS data.
-
TFA cleavage cocktails and scavengers: how the final deprotection step shapes a synthetic peptide's impurity profile
Acidolytic cleavage releases reactive carbocations that can modify Trp, Tyr, Met and Cys. Scavenger choice leaves a characteristic, detectable trace in the analytical record.
-
N-methylation of the peptide backbone: protease resistance, conformation, and what it does to characterization
Replacing a backbone amide hydrogen with a methyl group changes hydrogen bonding, cis/trans preference, and enzyme recognition — and complicates routine analytical methods.
-
ALCOA+ and the analytical record: what data integrity means for the chromatogram behind a peptide purity figure
A purity percentage is the end of a chain of acquisition, integration and review. Data integrity principles describe what has to be true of that chain.
-
Freeze–thaw cycles and peptide integrity: what repeated cycling does to a solution
Repeated freezing and thawing stresses reconstituted peptide solutions through concentration, pH shifts, and ice interfaces. Here is what the stability literature describes.
-
Mass accuracy, resolving power, and ppm error: what 'matches the theoretical mass' actually establishes
A reported mass match is only as informative as the instrument's accuracy and resolving power. This post explains ppm error, calibration, and the limits of mass alone.
-
Sodium and potassium adducts in electrospray spectra: reading the satellite peaks
Satellite peaks beside a peptide's main ion are often salt adducts, not impurities. This post explains how they form, how to recognize them, and what they imply.
-
b and y ions: how MS/MS fragmentation confirms a synthetic peptide sequence
An intact mass shows composition, not order. This post explains how collision-induced fragmentation produces b and y ion ladders and what they can and cannot establish.
-
pH-rate profiles for peptide degradation: why no single pH suits every pathway
Hydrolysis, deamidation, oxidation and aggregation each have their own pH dependence. This post explains how pH-rate profiles are built and why formulation pH is a compromise.
-
Hygroscopicity in lyophilized peptides: moisture uptake, equilibration, and weighing error
Lyophilized peptide cakes are often hygroscopic. This post covers vapor sorption behavior, why cold vials gain water on opening, and how static and humidity affect weighing.
-
Ellman's reagent and free thiol quantitation: what a cysteine count tells you about a peptide's disulfide status
Ellman's assay measures free sulfhydryl groups colorimetrically. This post reviews the chemistry, its limits, and how thiol data complements LC-MS.
-
Monoisotopic versus average mass: reading a peptide mass spectrum without fooling yourself
Why a peptide's observed mass depends on isotope envelopes and charge states, and how monoisotopic and average masses are matched to a theoretical value.
-
Diketopiperazine formation at the N-terminus: how a free amine can excise the first two residues
Diketopiperazine formation can cleave the first two residues from a peptide during synthesis or storage. This post reviews the mechanism and analytical signs.
-
The Asp-Pro bond: why one dipeptide is acid-labile and what it means for stored peptides
Aspartyl-prolyl bonds hydrolyze in mild acid far faster than other peptide bonds. The mechanism, pH dependence, and analytical signatures of Asp-Pro cleavage.
-
TFA versus formic acid in peptide LC-MS: ion pairing, signal suppression, and why one method may not serve both detectors
Mobile phase acid choice shapes both peak shape and mass spectrometric sensitivity. This post reviews ion pairing, signal suppression, and method trade-offs.
-
N-terminal acetylation and C-terminal amidation: terminal modifications and how they are verified
Terminal capping changes a peptide's charge, mass, and chromatographic behavior. This post reviews how acetylation and amidation are characterized analytically.
-
Aspartimide formation in Asp-Xaa sequences: a succinimide pathway in synthesis and storage
Aspartimide formation links solid-phase synthesis artifacts and storage degradation. A look at the mechanism, sequence dependence, and why the byproducts are hard to resolve.
-
HILIC for polar peptides: retention logic where reversed-phase falls short
Hydrophilic interaction chromatography retains the small, polar, highly charged peptides that elute near the void in reversed-phase. A look at the mechanism, method variables, and COA implications.
-
Peak purity in peptide HPLC: the limits of spectral homogeneity
A diode-array peak purity pass is routinely read as proof that one chromatographic peak is one compound. For peptides, the chromophore makes it a weak one.
-
Osmolality, osmolarity, and tonicity: three numbers for one reconstituted solution
Osmolality counts dissolved particles, osmolarity is converted from it, and tonicity depends on which of those particles a given membrane refuses to pass.
-
PEGylation: what attaching a polymer does to a peptide's analytical profile
PEGylation extends peptide half-life through hydrodynamic bulk. But a polydisperse polymer turns one analyte into a distribution, changing what purity means.
-
Registered is not approved: the 503B outsourcing facility and the unit its status attaches to
Section 503B registration is a status held by a facility, not a clearance held by a product. That distinction governs what the designation can support.
-
Lot sampling and retains: what a CoA result is representative of
A certificate of analysis reports a measurement on a sample, not on a vial. What connects the two is a sampling plan — and that plan is rarely stated.
-
Shipper qualification: what a 72-hour rating is indexed to
A 72-hour shipper rating is a chamber result against one ambient profile at one payload configuration — not a duration the package carries into any lane.
-
DSCSA and the serialized supply chain: what pharmaceutical traceability covers, and what sits outside it
The Drug Supply Chain Security Act traces prescription drugs in finished dosage form. Its statutory unit, its data elements, and its exclusions all matter.
-
Antimicrobial effectiveness testing: what "bacteriostatic" establishes, and what dilution does to it
A bacteriostatic label reports a challenge-test result on a diluent as supplied — not a property the solution keeps once a peptide is reconstituted into it.
-
Import alerts and detention without physical examination: what a border refusal establishes, and what it does not
Detention without physical examination refuses entry on an appearance of violation, not a laboratory finding — and the difference governs what the record shows.
-
Difficult sequences: why some peptides resist assembly on the resin
Some sequences resist assembly on resin. On-resin aggregation, pseudoproline dipeptides, and backbone amide protection explain why — and what it costs.
-
Dry ice and peptide samples: sublimation, carbon dioxide, and the pH shift nobody records
Dry ice is not an inert cold source. It fills a shipper with carbon dioxide, and a sample thawed from that atmosphere can reach a pH it was never formulated at.
-
The DMF reference on a peptide listing: what a Drug Master File is, and what invoking one would require
A Drug Master File is a confidential FDA submission that means something only inside a referencing drug application — not a quality grade a listing can claim.
-
Proline cis–trans isomerization: when two chromatographic peaks are one peptide
A proline-containing peptide can elute as two peaks of identical mass with no impurity present. What causes conformational doubling, and how to identify it.
-
System suitability testing: what the injections before your sample are meant to prove
A purity figure is only as good as the instrument that made it. What resolution, tailing, and injection-repeatability checks establish — and what they cannot.
-
Native chemical ligation: how long peptides get built when stepwise synthesis runs out of room
Stepwise chain assembly degrades with length. Chemoselective ligation joins purified fragments instead — and leaves a different impurity record behind.
-
Sterile filtration of peptide solutions: membrane chemistry, adsorptive loss, and what passes through
A 0.22 µm filter is rated by pore size, but for peptides the membrane polymer matters more: what binds, what leaches, and how much never reaches the vial.
-
"GMP-grade" on a peptide listing: what ICH Q7 covers and where GMP actually begins
GMP is a claim about a manufacturer’s quality system, not a property of a molecule. Where that boundary falls in peptide synthesis, and why a CoA cannot show it.
-
Universal detection for peptides without a chromophore: charged aerosol detection and ELSD against UV
Many synthetic peptides absorb poorly above 250 nm. How CAD and ELSD respond by mass rather than absorbance, and what that changes on a purity chromatogram.
-
Quantitative NMR for synthetic peptides: an absolute assay that does not require a matching reference standard
qNMR ties peptide content to a certified internal standard through proton count alone. What the technique measures, where it outperforms AAA, and its limits.
-
Edman degradation: the sequence question that intact mass cannot close
Intact mass confirms composition, not order. What stepwise N-terminal sequencing still establishes about a synthetic peptide, and where the chemistry runs out.
-
The 40-residue line: where a peptide stops being a drug and becomes a biologic
One number decides whether an amino acid polymer is regulated as a drug or a biological product. Where the 40-residue threshold came from and how it is counted.
-
Glass transition and collapse temperature: the thermal numbers behind lyophilized peptide stability
A lyophilized peptide cake is an amorphous glass. Two temperatures govern it: the collapse temperature during drying and the glass transition in storage.
-
Stability programs and retest dates: where a lyophilized peptide's storage window actually comes from
A peptide vial's storage window is the output of a stability study, not an estimate. ICH Q1A defines how those studies are designed and what the date means.
-
Reference standards in peptide analysis: what the purity number is measured against
Every purity and content figure on a peptide COA is a comparison. The material on the other side of that comparison is the reference standard, and its qualification sets the ceiling on what the result can mean.
-
Impurity thresholds for synthetic peptides: the number underneath the purity figure
A purity result is a boundary. Threshold frameworks define how far below it anyone is obliged to look — and that definition changed for peptides in July 2026.
-
Fmoc versus Boc solid-phase synthesis: how the protecting-group strategy shapes the final material
Two protection schemes build the same sequence by different chemistry. The choice propagates into the impurity fingerprint and the residual solvent profile.
-
Ion-exchange chromatography for peptide charge variants: what RP-HPLC misses
Reversed-phase HPLC separates by hydrophobicity, so charge variants often co-elute with the main peak. Ion-exchange chromatography resolves them by net charge.
-
Container closure integrity: how vial seals are tested and what a leak actually costs
A vial's seal is a measurable variable, not an assumption: how leakage limits are defined, why dye ingress fell out of favor, and what headspace gas reveals.
-
Macrocyclization and conformational constraint in peptide research
Closing a peptide into a ring reshapes its conformational ensemble and protease susceptibility — and quietly disables several standard characterization methods.
-
Sub-visible particulate matter in reconstituted peptide solutions
A solution that looks clear can still carry tens of thousands of particles per container. What light obscuration counts, what it misses, and why peptides complicate it.
-
Capillary electrophoresis as an orthogonal purity method for synthetic peptides
RP-HPLC separates peptides by hydrophobicity; capillary electrophoresis by charge-to-size ratio. Where the two disagree is where the information sits.
-
Elastomeric closures: extractables, leachables, and stopper chemistry in peptide vial storage
The rubber stopper is the most chemically complex part of a peptide vial. Elastomer formulation, coatings, and what actually migrates into the solution.
-
Circular dichroism and peptide higher-order structure: what a CD spectrum can and cannot settle
CD reports backbone conformation, not sequence. What the far-UV spectrum of a synthetic peptide actually establishes, and the ways it is routinely over-read.
-
The July 2026 PCAC meeting: seven peptides and how the 503A bulks list actually works
BPC-157, KPV, TB-500, MOTS-c, Emideltide, Semax and Epitalon went before FDA's compounding advisory committee. What that process does and does not decide.
-
Fatty acid acylation and albumin binding: the structural chemistry behind long-acting peptides
A gamma-Glu spacer, two ethylene glycol units and a C18 diacid turn a peptide with a two-minute half-life into one measured in days. Here is the chemistry.
-
What "validated method" means on a peptide certificate: ICH Q2, verification, and the limits of system suitability
A certificate calling its purity method validated is making a narrowly scoped claim. What ICH Q2 requires, and why a passing system suitability run is not it.
-
Residual solvents in synthetic peptides: what ICH Q3C covers, what it does not, and why headspace GC struggles with the ones that matter
Every peptide passes through DMF, piperidine, TFA and acetonitrile. The solvents most likely to remain are the ones the standard method is worst at seeing.
-
Lyoprotectants and bulking agents: what else is in a lyophilized peptide vial
Mannitol builds the cake and sucrose protects the peptide. These are different chemical jobs, and the excipient that does one usually cannot do the other.
-
Nitrosamine impurities in peptides: where NDSRIs come from and why routine testing does not look for them
Nitrosation needs a secondary amine and a nitrosating agent. Peptides supply both more often than expected, and the product is invisible to area-percent purity.
-
Glass vial chemistry: borosilicate types, delamination, and what the container contributes to peptide stability
Type I borosilicate glass is not inert. A look at glass composition, silanol surface chemistry, delamination risk, and container effects on stored peptides.
-
UV quantitation of peptides: what A280 measures, and what it quietly assumes
UV absorbance is the fastest way to estimate peptide concentration. Its accuracy hinges on extinction coefficients, chromophore content, and matrix effects.
-
Amino acid analysis: the reference method that anchors peptide content to an absolute scale
HPLC purity is a relative measurement. Amino acid analysis is the absolute one. How hydrolysis, derivatization, and internal standards produce peptide content.
-
Pyroglutamate formation: the N-terminal cyclization that hides in a −17 Da mass shift
N-terminal glutamine can cyclize to pyroglutamate, shifting mass by −17 Da and blocking the free amine. The mechanism, kinetics, and analytical signatures.
-
Peptide mapping and enzymatic digestion: localizing the modifications intact mass can't place
Intact mass shows that a modification happened, not where. How peptide mapping and LC-MS/MS localize oxidation, deamidation, and sequence errors to the residue.
-
Temperature excursions and mean kinetic temperature: what transit conditions mean for peptide stability
A shipment that sat in a hot truck raises a kinetics question, not a binary one. Arrhenius behavior and mean kinetic temperature frame the excursion problem.
-
Oxidative degradation in stored peptides: which residues go first, and what drives them
Oxidation is the most common storage-related degradation pathway in peptides, but it is not uniform. A look at susceptible residues and what drives them.
-
Disulfide scrambling: why two peptides with identical mass can be different molecules
Disulfide isomers share a sequence, a formula, and a mass. What separates them is connectivity — and most routine peptide identity testing cannot see it.
-
Residual moisture in lyophilized peptides: what a Karl Fischer number actually measures
Water content is the least-read number on a peptide CoA. What Karl Fischer titration measures, how it differs from loss on drying, and why the value moves.
-
Forced degradation studies: how a peptide purity method proves it can actually see degradation
A purity assay is only meaningful if it detects the degradants that form. How stress testing under acid, base, oxidation, heat, and light validates peptide methods.
-
Racemization and chiral purity: the peptide impurity that is invisible to both HPLC and mass spectrometry
A D-amino acid impurity has the same mass as the target and often the same retention time. What racemization does to a peptide, and how it is measured.
-
Elemental impurities in synthetic peptides: what ICH Q3D covers and why HPLC cannot see it
Chromatographic purity says nothing about trace metals. Where elemental impurities enter synthetic peptides, and how ICP-MS characterizes them.
-
Peptide aggregation: why soluble oligomers are invisible to a purity certificate
Aggregation removes peptide from solution without altering mass or covalent structure — which is exactly why RP-HPLC and mass spectrometry do not detect it.
-
Asparagine deamidation: the one-dalton degradation route that purity assays miss
Asparagine deamidation is the slowest-looking and most consequential peptide degradation route: a one-dalton mass shift that standard purity assays miss.
-
Light exposure and peptide photodegradation: which residues absorb, and what happens next
Only a few amino acid residues absorb near-UV light, but their photochemistry drives most light-related peptide degradation. A look at the mechanisms.
-
Surface adsorption and peptide loss: container materials, low-concentration handling, and mass balance
Peptides adsorb to glass, plastic, and filter surfaces. At low concentrations this loss is large enough to distort analytical results. A look at the chemistry.
-
Where synthetic peptide impurities come from: deletion, truncation, and side-chain artifacts in SPPS
Most impurities in a synthetic peptide are created during synthesis, not during storage. A look at deletion sequences, truncations, and side-chain artifacts.
-
Peptide solubility: isoelectric point, net charge, and why some sequences resist reconstitution
Solubility is a sequence property, not a quality defect. How isoelectric point, net charge, and hydrophobic patterning govern whether a peptide dissolves.
-
Peptide counterions: what TFA and acetate salt forms mean for research material
Synthetic peptides are isolated as salts. Why trifluoroacetate dominates RP-HPLC purification, how acetate exchange works, and what counterion data mean.
-
Why two labs report different purity for the same peptide lot: RP-HPLC method variables
Two labs can report different purity figures for the same peptide lot. The RP-HPLC variables behind that gap: column chemistry, gradient slope, wavelength.
-
Endotoxin testing for research peptides: what LAL assays measure and what an EU/mg value means
Endotoxin is invisible to HPLC and mass spectrometry, so a 99% pure peptide can still carry a significant endotoxin burden. This post covers what the LAL assay detects and how to read an EU/mg figure on a certificate of analysis.
-
Peptide content vs chromatographic purity: why a 99% COA does not tell you how much peptide is in the vial
Chromatographic purity and peptide content measure different things. A lyophilate can be 99% pure by HPLC and still be 20% counterion and water by mass. This post covers the distinction and how each value is determined.
-
How mass spectrometry verifies peptide identity: MALDI-TOF vs ESI-MS
Purity and identity are separate questions, and chromatography only answers the first. This post covers how MALDI-TOF and ESI-MS establish that a peptide is the molecule it claims to be, and how to read the mass data on a certificate of analysis.
-
Freeze-thaw cycles and peptide integrity: what happens at the molecular level
Each freeze-thaw cycle exposes a peptide to cryoconcentration, ice-interface adsorption, and pH shifts. This post covers the degradation mechanisms and how aliquoting practice is designed around them.
-
GLP-1/GIP/Glucagon: The tri-agonist and multi-agonist peptide landscape in 2026
The obesity and metabolic peptide research space has shifted decisively toward multi-receptor agonists. This overview covers every major dual, triple, and combination agonist currently in clinical development.
-
Bacteriostatic water vs sterile water: the chemistry of peptide reconstitution
Bacteriostatic water contains 0.9% benzyl alcohol as a preservative; sterile water does not. This post explains what that difference means for peptide reconstitution chemistry, working stock stability, and analytical considerations.
-
Semaglutide COA: What to look for in a certificate of analysis
A certificate of analysis for research-grade semaglutide should report mass verification, HPLC purity, water content, and endotoxin. Here's what each value means and how to spot a legitimate lab report.
-
Retatrutide vs Tirzepatide: How triple- and dual-agonists differ
Retatrutide is a triple agonist at GLP-1, GIP, and glucagon receptors. Tirzepatide is a dual GLP-1/GIP agonist. This post explains what the third receptor changes about mechanism and metabolic effect.
-
What is Cagrilintide? An amylin analog research overview
Cagrilintide is a long-acting amylin analog studied for its effects on appetite regulation and glucose metabolism, most notably in combination with semaglutide (CagriSema). This overview covers its mechanism, pharmacology, and current research landscape.
-
Storage Solvent Chemistry: Diluents for Research Peptides
The diluent — the solvent used to reconstitute a lyophilized research peptide — is not a neutral choice. It determines the rate at which the dissolved peptide degrades, the stability of the working stock, the…
-
What is Mazdutide? An Oxyntomodulin-Derived Dual Agonist
Mazdutide (development codes IBI362 and LY3305677) is a synthetic dual-receptor research peptide engineered from the oxyntomodulin backbone — the natural human peptide that endogenously engages both the GLP-1 receptor…
-
GHRP-2 vs GHRP-6: A Growth Hormone Secretagogue Research Comparison
GHRP-2 and GHRP-6 are two of the founding members of the synthetic growth hormone-releasing peptide (GHRP) class — short peptide ghrelin-receptor agonists characterized in the late 1980s and early 1990s. Both bind the…
-
Liraglutide Research Overview: The Original Long-Acting GLP-1 Agonist
Liraglutide was the first long-acting glucagon-like peptide-1 (GLP-1) receptor agonist to be characterized at the molecular level, and remains the prototype research compound for studying acylation-mediated half-life…
-
The GLP-1 Research Landscape, Q2 2026
The incretin-axis research peptide category has expanded rapidly over the last five years. What was once a small set of GLP-1 receptor agonist research probes has grown into a multi-mechanism toolkit spanning…
-
Lyophilization Chemistry: Why Research Peptides Come as Powder
Open any research peptide vial from any vendor and the contents look the same: a thin layer of white-to-off-white powder or a small puck of friable solid at the bottom of the vial. That puck is the result of…
-
SS-31 (Szeto-Schiller Peptide) Mechanism: Mitochondria-Targeted Tetrapeptide
SS-31 — also designated elamipretide in the development literature, and named for its developers Hazel Szeto and Peter Schiller — is a small synthetic tetrapeptide engineered to selectively concentrate at the inner…
-
Tesamorelin Research Overview: GHRH Analog Mechanism and Preclinical Findings
Tesamorelin is a synthetic stabilized analog of growth hormone-releasing hormone (GHRH) — specifically, the GHRH(1-44) full-length sequence modified by attachment of a trans-3-hexenoyl moiety to the N-terminal tyrosine.…
-
What is Survodutide? A GLP-1/Glucagon Dual Agonist Research Overview
Survodutide (development code BI 456906) is a synthetic dual-receptor research peptide engineered to simultaneously activate the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). In the…
-
MOTS-c: A Mitochondrial-Derived Peptide Research Overview
MOTS-c — “Mitochondrial Open Reading frame of the Twelve S rRNA type-c” — is a 16-amino-acid peptide encoded within the mitochondrial 12S ribosomal RNA gene. It is one of the most-studied members of the…
-
Sermorelin vs CJC-1295: A Research Comparison of GHRH Analogs
Sermorelin and CJC-1295 are both synthetic analogs of growth hormone-releasing hormone (GHRH), and both bind the same hypothalamic-pituitary GHRH receptor (GHRHR) to drive somatotroph signaling. The difference between…
-
Cagrilintide Mechanism and Amylin Biology: A Research Overview
Cagrilintide is a long-acting synthetic analog of human amylin — the pancreatic hormone co-secreted with insulin from β-cell granules in response to a glucose load. Where the incretin class (GLP-1, GIP) signals from the…
-
Reading a Tirzepatide CoA: What Each Value Means
A Certificate of Analysis is the only document that connects a vial of lyophilized white powder to a defined molecular identity. For a 39-amino-acid lipidated peptide like tirzepatide, the CoA carries unusual weight:…
-
Tirzepatide Mechanism Deep-Dive: GLP-1/GIP Dual Agonism in Research Context
Tirzepatide is the prototype dual-incretin research peptide — a synthetic 39-amino-acid analog engineered to simultaneously activate the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic…
-
FDA Peptide Enforcement: What 2026 Brought
The U.S. research peptide market underwent its biggest regulatory transition in a decade between late 2024 and early 2026.
-
Thymosin Alpha-1: Immune Modulation Research
Thymosin Alpha-1 is one of the most-studied immune-modulating peptides in the published literature.
-
GHK vs GHK-Cu: What’s the Difference in the Research?
Few questions come up more often in the peptide research category than this one: are GHK and GHK-Cu the same thing, and if not, which one does the published literature actually describe? The two names are used interchangeably in marketing copy, in supplier listings, and even in some review articles.
-
Understanding Peptide Purity: What 99% Actually Means
Almost every research peptide certificate of analysis (CoA) you'll pick up displays a purity figure — and that figure is almost always 99% or higher. On its face, this looks like a settled question: a vial is either pure or it isn't.
-
How to Verify a Peptide Lot in 90 Seconds
You have a vial in your hand. The label says BPC-157, 10 mg, with a lot number printed under the barcode.
-
BPC-157 vs. TB-500: A Research Comparison
BPC-157 and TB-500 are the two peptides most frequently compared in the tissue-repair and soft-tissue research literature.
-
Peptide Research Glossary: A Beginner’s Reference to the Terminology
The vocabulary of peptide research is its own dialect. A vial label, a Certificate of Analysis, and a published animal-research paper all assume the reader knows the basics: what a peptide actually is, what HPLC measures, what \"lyophilized\" means, what \"RUO\" stands for.
-
Why Third-Party CoAs Matter: An Industry-Standards Explainer for Research Peptide Buyers
A Certificate of Analysis (CoA) is the analytical record that a research-peptide vendor presents to attest to the identity and purity of a specific manufacturing lot.
-
Melanotan 2 and the Melanocortin Receptor Family: A Research Overview
Melanotan 2 (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH), the endogenous melanocortin-system peptide derived from proopiomelanocortin (POMC).
-
Sermorelin and the GHRH Analog Class: A Research Overview
Sermorelin is a synthetic 29-amino-acid peptide that corresponds to the first 29 residues of growth hormone-releasing hormone (GHRH), the endogenous hypothalamic peptide that stimulates somatotroph release of growth hormone (GH) from the anterior pituitary.
-
Reconstitution Math: Calculating Concentration from a mg-per-Vial Lyophilized Peptide
A lyophilized research peptide arrives as a powder labeled with a gross mass — typically 5 mg, 10 mg, or higher. To use the compound in any research application, the powder must be dissolved in solvent, and the resulting solution must have a known, calculable concentration.
-
TB-500 (Thymosin Beta-4): A Research Overview of an Actin-Sequestering Peptide
TB-500 is a synthetic research peptide based on the 17-amino-acid active sequence of thymosin beta-4, a small actin-sequestering protein originally isolated from calf thymus in the early 1980s. The full-length parent molecule, thymosin beta-4, is the most abundant member of the b
-
Retatrutide vs. Semaglutide: A Research Comparison
Semaglutide and retatrutide are the two compounds most commonly compared in the current GLP-1 research literature, but the comparison is somewhat lopsided: semaglutide is an approved, marketed...
-
NAD+ in Research: Mechanism, Sirtuin Biology, and Storage Considerations
Nicotinamide adenine dinucleotide — NAD+ in its oxidized form — sits at the center of cellular metabolism and a body of aging-biology research that has expanded dramatically over the past decade....
-
GHK-Cu: The Copper Peptide in Skin and Tissue Research
GHK-Cu — the copper-bound complex of the tripeptide glycyl-L-histidyl-L-lysine — is one of the most-studied small peptides in regenerative biology. Loren Pickart's 1973 isolation of the GHK...
-
Lyophilized vs. Reconstituted Peptides: A Storage Protocol Guide
The lyophilized form of a research peptide is dramatically more stable than the reconstituted form — by orders of magnitude, in most cases. A properly stored lyophilized peptide maintains high...
-
BPC-157: A Complete Research Overview
BPC-157 — short for body protection compound 157, a pentadecapeptide first isolated from a fragment of human gastric juice protein — is one of the most-studied research peptides of the last twenty...
-
How to Read a Peptide Certificate of Analysis (CoA): A Practical Guide for Researchers
A peptide Certificate of Analysis is the single document that distinguishes a reproducible research input from a black box. The CoA is the vendor's claim about what is actually in the vial,...
-
How to Properly Store Research Peptides: A Complete Guide
Best practices for storing lyophilized and reconstituted research peptides, including temperature guidelines, reconstitution tips, and common mistakes to avoid.
-
Understanding Certificates of Analysis (COAs): Why They Matter
Learn how to read and evaluate a Certificate of Analysis (COA), why third-party testing matters, and what to look for when sourcing research peptides.
-
What Are Peptides? A Comprehensive Guide for Researchers
A detailed overview of peptides — what they are, how they differ from proteins, and why they are essential tools in modern scientific research.